Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U._1 type RangedSequencePosition NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U.assertion.
- NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U._1 type SO_0001148 NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U.assertion.
- NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U._1 comment "No effect on interaction with CUEDC2. Impaired progesterone-induced transcriptional activity. No CUEDC2- nor progestin-mediated protein degradation. No change in sumoylation; when associated with A-344 and A-345." NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U.assertion.
- NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U._1 SIO_000053 NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U._2 NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U.assertion.
- NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U._1 SIO_000053 NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U._3 NX_P06401-2_MUTAGEN_130_130.RAhxznCcRoMeNkG_JdKfRF9Q08rceJjV1bOYiQqIs8D6U.assertion.